Market Cap | ₹1,163Cr |
ROE | 7.41% |
P/E Ratio(TTM) | -127.68 |
EPS(TTM) | -0.99 |
P/B Ratio | 3.15 |
Dividend Yield | 0.40% |
Industry P/E | 35.18 |
Book Value | 40.16 |
Debt to Equity | 0.21 |
Face Value | 1 |
Parent Organisation | Themis Medicare |
Managing Director | Dr. Sachin Patel |
NSE Symbol | THEMISMED |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 104.62 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.68 | ||
Emcure Pharmaceuticals | NA (0.00%) | 34.29 | ||
Wockhardt | NA (0.00%) | -149.63 |